Frontiers in Clinical Drug Research – Diabetes and Obesity

Volume 2

by

Atta-ur-Rahman

DOI: 10.2174/97816810818541160201
eISBN: 978-1-68108-185-4, 2016
ISBN: 978-1-68108-186-1
ISSN: 2467-9607 (Print)
ISSN: 2352-3220 (Online)



Recommend this eBook to your Library



Frontiers in Clinical Drug Research – Diabetes and Obesity is an eBook series t...[view complete introduction]

Table of Contents

Preface

- Pp. i

Atta-ur-Rahman

Download Free

List of Contributors

- Pp. iii

Atta-ur-Rahman

Download Free

The Current, Emerging and Future Medications for Type 2 Diabetes and Obesity

- Pp. 3-49 (47)

Hidesuke Kaji

View Abstract Purchase Chapter

Antidiabetic Drugs of Type 2 Diabetes and Obesity

- Pp. 50-59 (10)

Tatjana Ábel and Gabriella Lengyel

View Abstract Purchase Chapter

Sodium-Glucose Co-Transport Inhibitors: A New Therapeutic Option for Type 2 Diabetes Mellitus

- Pp. 60-83 (24)

Athanasia K. Papazafiropoulou and Marina S. Kardara

View Abstract Purchase Chapter

Osteocalcin Plays as an Endocrine Hormone in Glucose Metabolism

- Pp. 84-101 (18)

Ippei Kanazawa

View Abstract Purchase Chapter

Emerging Therapeutic Agents for the Treatment of Type 2 Diabetes Mellitus

- Pp. 102-149 (48)

Shivaprasad Channabasappa and Krishnan M. Prasanna Kumar

View Abstract Purchase Chapter

Advances in New Drugs for Diabetes Treatment: GLP-1 Mimetics and DPP-4 Inhibitors

- Pp. 150-188 (39)

Xianglan Sun, Yao Wang and Minglong Li

View Abstract Purchase Chapter

New and Promising Drugs for Obesity

- Pp. 189-234 (46)

Natalia G. Vallianou, Angelos A. Evangelopoulos and Christos E. Kazazis

View Abstract Purchase Chapter

Subject Index

- Pp. 235-243 (9)

Atta-ur-Rahman

Download Free

Preface

Frontiers in Clinical Drug Research – Diabetes and Obesity Volume comprises seven comprehensive chapters discussing novel approaches to combat diabetes and obesity.

In Chapter 1, Kaji discusses the clinical trials conducted for evaluating the current, emerging and future medications for treating Type 2 diabetes and obesity. They also highlight the new drug candidates that are under consideration.

Overweight and obesity are the risk factors for type 2 diabetes and they also influence the overall prognosis. In Chapter 2, Abel and Lengyel emphasize that in order to prevent the development of complications, the antidiabetic therapies are designed to reduce and maintain the glucose concentrations.

Kidney plays a vital role in maintaining the level of glucose production and absorption. The major portion of glucose that enters into the kidney is reabsorbed in the tubular system, which helps in maintaining the glucose plasma level. Due to certain malfunctioning, glucose may not get properly reabsorbed in the tubular system that can lead to the condition of glycosuria. Sodium-coupled glucose transporters 2 (SGLTs-2) play an important role in glucose reabsorption. In Chapter 3 Papazafiropoulou and Kardara highlight the role of Sodium-Glucose Co-Transport Inhibitors as a new therapeutic approach for type 2 diabetes mellitus.

Kanazawa draws attention towards the impact of Osteocalcin on glucose metabolism in Chapter 4. Osteocalcin prevents the risk of diabetes mellitus by increasing the expression of insulin in pancreatic b-cells as well as adiponectin in adipocytes. Kanazawa presents an overview of the clinical studies, suggesting that glucose homeostasis and bone metabolism is linked together through the action of osteocalcin.

In Chapter 5, Channabasappa and Prasanna Kumar review the various new targets for diabetes and they propose that long acting GLP-1 (Glucagon-like Peptide-1 ) analogues, DPP-4 (Dipeptidyl peptidase-4) inhibitors and newer gliptins may be important in the discovery of anti-diabetic therapies. Similarly, in Chapter 6, Li et al. focus on incretin impairment that commonly exists in both obesity and diabetes, so it is necessary to work on incretin based therapies for the prevention and cure of diabetes and obesity.

In Chapter 7, Vallianou and colleagues discuss the importance of GLP-1 receptor agonists, and the 5- HT2C selective serotonin receptor agonists oxyntomodulin, oxytocin, orexin and PPARγ (peroxisome proliferator agonist receptor γ) that seem to be effective in the eradication of obesity.

I am very grateful to all the authors for their outstanding contributions. I would also like to appreciate the efforts of the dedicated team of Bentham Science Publishers, especially Dr. Faryal Sami (Assistant Manager Publications), Mr. Shehzad Naqvi (Senior Manager Publications) and Mr. Mahmood Alam (Director Publications).

Prof. Atta-ur-Rahman, FRS
Kings College
University of Cambridge
Cambridge
UK

List of Contributors

Editor(s):
Prof. Dr. Atta-ur-Rahman
Kings College
University of Cambridge
Cambridge
UK




Contributor(s):
Angelos A. Evangelopoulos
Roche Hellas Diagnostics
Αthens
Greece


Athanasia K. Papazafiropoulou
1st Department of Internal Medicine & Diabetes Center General Hospital of Piraeus "Tzaneio"
Greece


Christos E. Kazazis
Leicester University
London
UK


Gabriella Lengyel
2nd Department of Internal Medicine, Medical Faculty
Semmelweis University
Budapest
Hungary


Hidesuke Kaji
Division of Physiology and Metabolism
University of Hyogo
Akashi, Hyogo
Japan


Ippei Kanazawa
Department of Internal Medicine 1
Shimane University Faculty of Medicine
Shimane
Japan


Krishnan M. Prasanna Kumar
Center for Diabetes and Endocrine Care
Banglore
India


Marina S. Kardara
Health Center of Erymantheia
Achaia
Greece


Minglong Li
Department of Endocrinology
Provincial Hospital affiliated to Shandong University
Jinan, China


Natalia. G Vallianou
Evangelismos General Hospital Athens
Greece


Shivaprasad Channabasappa
Department of Endocrinology and Metabolism
Vydehi Institute of Medical Sciences & Research Centre
Banglore, India


Tatjana Ábel
Outpatient Department
Military Hospital
Budapest
Hungary
/
Faculty of Health Sciences
Semmelweis University
Budapest
Hungary


Xianglan Sun
Department of Endocrinology
Provincial Hospital affiliated to Shandong University
Jinan
China


Yao Wang
Shandong Institute of Endocrine and Metabolic Diseases
Shandong Academy of Medical Sciences
Jinan, 250062 Shandong
China




Advertisement


Related Journals



Related Books



Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science